首页 > 最新文献

Biomeditsinskaya khimiya最新文献

英文 中文
Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial. Vitaphospholip®(水溶性磷脂酰胆碱)治疗合并高脂血症:一项随机、安慰剂对照临床试验
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-11-01 DOI: 10.18097/PBMCR1619
V V Kukharchuk, E A Ponomarenko, A V Lisitsa, Yu A Romashova, T O Pleshakova, E B Yarovaya, V A Kutsenko, M K Guseva, O M Ipatova, E A Karpova, M Yu Zubareva, A M Pyatigorsky, S V Ivanov, V V Beregovykh, D A Kudlai, S S Markin, A I Archakov

Vitaphospholip®, a water-soluble form of phosphatidylcholine, has been evaluated in a clinical trial aimed at reducing non-HDL-cholesterol (non-HDL-C) and triglyceride (TG) levels in patients with combined hyperlipidemia. The randomized, double-blind, placebo-controlled study included 100 patients. Vitaphospholip® or placebo was administered orally 500 mg twice a day for 12 weeks.Treatment with Vitaphospholip® resulted in a 13.2% decrease in non-HDL-C compared to 4.3% in the placebo group (p = 0.001). The absolute decrease of non-HDL-C was 0.6 mmol/l compared to -0.2 mmol/l in the placebo group (p = 0.001). The target non-HDL-C level of less than 3.4 mmol/L was achieved in 15 of 39 patients (38.5%) in the Vitaphospholip® group versus 2 of 41 patients (4.9%) in the placebo group (p = 0.000). The absolute decrease of TG in the group of patients treated with Vitaphospholip® was -0.7 mmol/l versus -0.1 mmol/L in the placebo group (p = 0.001). During therapy with Vitaphospholip®, a significant decrease in the levels of apolipoprotein B, total cholesterol, and very low-density lipoprotein cholesterol was observed. No changes in liver or kidney function, vital signs, or ECG were registered. No serious adverse events were identified. Thus, Vitaphospholip® significantly reduced the levels of non-HDL-C, TG, and atherogenic lipoprotein in patients with combined hyperlipidemia and moderate cardiovascular risk.

Vitaphospholip®是一种水溶性磷脂酰胆碱,已在一项旨在降低合并高脂血症患者非高密度脂蛋白胆固醇(non-HDL-C)和甘油三酯(TG)水平的临床试验中进行评估。这项随机、双盲、安慰剂对照的研究包括100名患者。Vitaphospholip®或安慰剂口服500毫克,每天两次,持续12周。Vitaphospholip®治疗导致非hdl - c下降13.2%,而安慰剂组为4.3% (p = 0.001)。非hdl - c的绝对降低为0.6 mmol/l,而安慰剂组为-0.2 mmol/l (p = 0.001)。Vitaphospholip®组39例患者中有15例(38.5%)达到了低于3.4 mmol/L的非hdl - c目标水平,而安慰剂组41例患者中有2例(4.9%)达到了目标水平(p = 0.000)。Vitaphospholip®治疗组患者TG的绝对下降量为-0.7 mmol/l,而安慰剂组为-0.1 mmol/l (p = 0.001)。在使用Vitaphospholip®治疗期间,观察到载脂蛋白B、总胆固醇和极低密度脂蛋白胆固醇水平显著降低。肝肾功能、生命体征或心电图均无变化。未发现严重不良事件。因此,Vitaphospholip®可显著降低合并高脂血症和中度心血管风险患者的非hdl - c、TG和致动脉粥样硬化脂蛋白水平。
{"title":"Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial.","authors":"V V Kukharchuk, E A Ponomarenko, A V Lisitsa, Yu A Romashova, T O Pleshakova, E B Yarovaya, V A Kutsenko, M K Guseva, O M Ipatova, E A Karpova, M Yu Zubareva, A M Pyatigorsky, S V Ivanov, V V Beregovykh, D A Kudlai, S S Markin, A I Archakov","doi":"10.18097/PBMCR1619","DOIUrl":"10.18097/PBMCR1619","url":null,"abstract":"<p><p>Vitaphospholip®, a water-soluble form of phosphatidylcholine, has been evaluated in a clinical trial aimed at reducing non-HDL-cholesterol (non-HDL-C) and triglyceride (TG) levels in patients with combined hyperlipidemia. The randomized, double-blind, placebo-controlled study included 100 patients. Vitaphospholip® or placebo was administered orally 500 mg twice a day for 12 weeks.Treatment with Vitaphospholip® resulted in a 13.2% decrease in non-HDL-C compared to 4.3% in the placebo group (p = 0.001). The absolute decrease of non-HDL-C was 0.6 mmol/l compared to -0.2 mmol/l in the placebo group (p = 0.001). The target non-HDL-C level of less than 3.4 mmol/L was achieved in 15 of 39 patients (38.5%) in the Vitaphospholip® group versus 2 of 41 patients (4.9%) in the placebo group (p = 0.000). The absolute decrease of TG in the group of patients treated with Vitaphospholip® was -0.7 mmol/l versus -0.1 mmol/L in the placebo group (p = 0.001). During therapy with Vitaphospholip®, a significant decrease in the levels of apolipoprotein B, total cholesterol, and very low-density lipoprotein cholesterol was observed. No changes in liver or kidney function, vital signs, or ECG were registered. No serious adverse events were identified. Thus, Vitaphospholip® significantly reduced the levels of non-HDL-C, TG, and atherogenic lipoprotein in patients with combined hyperlipidemia and moderate cardiovascular risk.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 5","pages":"364-374"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145480703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The preconditioning effect of a structural analogue of apelin-12 in a rat model of acute myocardial infarction. apelin-12结构类似物在大鼠急性心肌梗死模型中的预适应作用。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-11-01 DOI: 10.18097/PBMCR1622
O M Veselova, L I Serebryakova, I M Studneva, A A Azmuko, A V Avdeev, M V Sidorova, O I Pisarenko

The use of pharmacological agents to trigger preconditioning mechanisms may improve the prevention and treatment of coronary heart disease. The aim of this study was to evaluate the ability of a structural analog of apelin-12 ((NαMe)Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Phe-OH, metilin) to reproduce the effect of ischemic preconditioning (IP) of rat hearts in vivo. Control rats were exposed to 40-min occlusion of the left descending coronary artery (LDCA) followed by 60-min restoration of coronary blood flow (reperfusion). IP was modeled by three cycles of 5-min occlusion/5-min reperfusion of the LDCA before prolonged regional myocardial ischemia and reperfusion. Metilin (5 mg/kg) was administered to rats intravenously by bolus injection 30 min before LDCA occlusion. IP or metilin had a significant impact on the studied parameters. The size of necrotic damage to the left ventricle, expressed as the percentage ratio of myocardial infarction/myocardial area at risk (MI/AAR, %), at the end of reperfusion was 26.9±2.0% and 29.3±2.6%, respectively, compared with 43.8±1.2% in the control (p < 0.01). The activity of creatine kinase-MB (CK-MB) in blood plasma decreased to 1026.1±93.9 IU/ml and 1195.2±142.0 IU/ml, respectively, compared with 1986.3±193.7 IU/ml in the control (p < 0.02). Administration of metilin, as well as IP, increased the reduced content of ATP, total adenine nucleotide pool (ΣAN) and phosphocreatine (PCr) in the AAR at the end of reperfusion compared to the control (p < 0.05-0.01). In the metilin group, the content of total creatine (ΣCr) in AAR was higher than in the control (p < 0.05). Intravenous administration of 5 mg/kg 5-hydroxydecanoate (5HD), an inhibitor of mitochondrial ATP-dependent K+ channels (mitoKATP), abolished the preconditioning effect of metilin, and increased the MI/AAR, %, and plasma CK-MB activity to values that insignificantly differed from the control (39.4±2.8% and 2258.2±179.1 IU/ml, respectively). Simultaneously, 5HD significantly reduced the ATP and ΣAN levels in AAR compared to those in the metilin group and the ATP, ΣAN, and PCr levels compared to the IP group. The results indicate that pharmacological preconditioning by metilin reduced cardiac ischemia/reperfusion injury via the involvement of mitoKATP in the mechanism of metilin action.

使用药物触发预处理机制可以改善冠心病的预防和治疗。本研究的目的是评估apelin-12的结构类似物((NαMe) arg - pro - arg - leu - ser - his - lys - gly - pro - nle - pro - pheoh, metilin)在体内复制大鼠心脏缺血预处理(IP)效果的能力。对照组大鼠左冠状降支(LDCA)闭塞40分钟,再灌注60分钟恢复冠状动脉血流。在长时间局部心肌缺血再灌注前,采用LDCA 5 min闭塞/5 min再灌注3个周期来模拟IP。在LDCA闭塞前30 min,大鼠静脉注射甲氧苄啶(5mg /kg)。IP或metilin对研究参数有显著影响。再灌注结束时,心肌梗死/心肌危险面积百分比(MI/AAR, %)分别为26.9±2.0%和29.3±2.6%,对照组为43.8±1.2% (p < 0.01)。血浆肌酸激酶mb (CK-MB)活性分别降至1026.1±93.9 IU/ml和1195.2±142.0 IU/ml,低于对照组的1986.3±193.7 IU/ml (p < 0.02)。再灌注结束时,与对照组相比,给予梅丁啉和IP增加了AAR中减少的ATP、总腺嘌呤核苷酸库(ΣAN)和磷酸肌酸(PCr)的含量(p < 0.05 ~ 0.01)。甲替林组AAR中总肌酸(ΣCr)含量高于对照组(p < 0.05)。静脉给予5 mg/kg线粒体atp依赖性K+通道(mitoKATP)抑制剂5-羟乙酸酯(5HD),可消除甲替林的预处理作用,并使MI/AAR、%和血浆CK-MB活性升高,与对照组相比差异不显著(分别为39.4±2.8%和2258.2±179.1 IU/ml)。同时,与metilin组相比,5HD显著降低了AAR中的ATP和ΣAN水平,与IP组相比,5HD显著降低了ATP、ΣAN和PCr水平。结果表明,甲替林的药理预处理通过mitoKATP参与甲替林的作用机制来减轻心肌缺血再灌注损伤。
{"title":"The preconditioning effect of a structural analogue of apelin-12 in a rat model of acute myocardial infarction.","authors":"O M Veselova, L I Serebryakova, I M Studneva, A A Azmuko, A V Avdeev, M V Sidorova, O I Pisarenko","doi":"10.18097/PBMCR1622","DOIUrl":"10.18097/PBMCR1622","url":null,"abstract":"<p><p>The use of pharmacological agents to trigger preconditioning mechanisms may improve the prevention and treatment of coronary heart disease. The aim of this study was to evaluate the ability of a structural analog of apelin-12 ((NαMe)Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Phe-OH, metilin) to reproduce the effect of ischemic preconditioning (IP) of rat hearts in vivo. Control rats were exposed to 40-min occlusion of the left descending coronary artery (LDCA) followed by 60-min restoration of coronary blood flow (reperfusion). IP was modeled by three cycles of 5-min occlusion/5-min reperfusion of the LDCA before prolonged regional myocardial ischemia and reperfusion. Metilin (5 mg/kg) was administered to rats intravenously by bolus injection 30 min before LDCA occlusion. IP or metilin had a significant impact on the studied parameters. The size of necrotic damage to the left ventricle, expressed as the percentage ratio of myocardial infarction/myocardial area at risk (MI/AAR, %), at the end of reperfusion was 26.9±2.0% and 29.3±2.6%, respectively, compared with 43.8±1.2% in the control (p < 0.01). The activity of creatine kinase-MB (CK-MB) in blood plasma decreased to 1026.1±93.9 IU/ml and 1195.2±142.0 IU/ml, respectively, compared with 1986.3±193.7 IU/ml in the control (p < 0.02). Administration of metilin, as well as IP, increased the reduced content of ATP, total adenine nucleotide pool (ΣAN) and phosphocreatine (PCr) in the AAR at the end of reperfusion compared to the control (p < 0.05-0.01). In the metilin group, the content of total creatine (ΣCr) in AAR was higher than in the control (p < 0.05). Intravenous administration of 5 mg/kg 5-hydroxydecanoate (5HD), an inhibitor of mitochondrial ATP-dependent K+ channels (mitoKATP), abolished the preconditioning effect of metilin, and increased the MI/AAR, %, and plasma CK-MB activity to values that insignificantly differed from the control (39.4±2.8% and 2258.2±179.1 IU/ml, respectively). Simultaneously, 5HD significantly reduced the ATP and ΣAN levels in AAR compared to those in the metilin group and the ATP, ΣAN, and PCr levels compared to the IP group. The results indicate that pharmacological preconditioning by metilin reduced cardiac ischemia/reperfusion injury via the involvement of mitoKATP in the mechanism of metilin action.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 5","pages":"342-350"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145480648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioinformatic identification of proteins with varying levels of post-translational modifications in a model of atherogenesis in mice. 在小鼠动脉粥样硬化模型中具有不同水平翻译后修饰的蛋白质的生物信息学鉴定。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1575
Yu V Miroshnichenko, A V Rybina, V S Skvortsov

Mass spectrometric data obtained using a model of tandem carotid artery stenosis in mice with unstable and stable atherosclerosis were analyzed to identify differences in the level of post-translational modifications (PTMs) of proteins. The original proteomic data obtained by Chen et al. [DOI: 10.1038/s42003-023-04641-4] and deposited in the PRIDE repository (identifier PXD030857) were used. Based on results of the bioinformatic analysis, 12 proteins with PTMs (methylation, acetylation, and phosphorylation) were selected; comparison of healthy and atherosclerotic vascular sections showed that the selected proteins were characterized by significant changes in the level of individual modified peptides. According to the literature data, all 12 proteins are involved in the process of atherogenesis. Our study thus revealed putative points of regulation of the atherogenesis processes at the PTM level.

利用不稳定和稳定动脉粥样硬化小鼠串联颈动脉狭窄模型获得的质谱数据进行分析,以确定蛋白质翻译后修饰(PTMs)水平的差异。本文使用Chen等人[DOI: 10.1038/s42003-023- 04441 -4]获得的原始蛋白质组学数据,并存储在PRIDE存储库(标识符PXD030857)中。根据生物信息学分析结果,选择了12个具有PTMs(甲基化、乙酰化和磷酸化)的蛋白;健康和动脉粥样硬化血管切片的比较表明,所选蛋白质的特征是单个修饰肽水平的显著变化。根据文献资料,这12种蛋白都参与了动脉粥样硬化的形成过程。因此,我们的研究揭示了PTM水平对动脉粥样硬化过程的调节。
{"title":"Bioinformatic identification of proteins with varying levels of post-translational modifications in a model of atherogenesis in mice.","authors":"Yu V Miroshnichenko, A V Rybina, V S Skvortsov","doi":"10.18097/PBMCR1575","DOIUrl":"https://doi.org/10.18097/PBMCR1575","url":null,"abstract":"<p><p>Mass spectrometric data obtained using a model of tandem carotid artery stenosis in mice with unstable and stable atherosclerosis were analyzed to identify differences in the level of post-translational modifications (PTMs) of proteins. The original proteomic data obtained by Chen et al. [DOI: 10.1038/s42003-023-04641-4] and deposited in the PRIDE repository (identifier PXD030857) were used. Based on results of the bioinformatic analysis, 12 proteins with PTMs (methylation, acetylation, and phosphorylation) were selected; comparison of healthy and atherosclerotic vascular sections showed that the selected proteins were characterized by significant changes in the level of individual modified peptides. According to the literature data, all 12 proteins are involved in the process of atherogenesis. Our study thus revealed putative points of regulation of the atherogenesis processes at the PTM level.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"308-313"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet functional activity in patients with immune thrombocytopenia. 免疫性血小板减少症患者的血小板功能活性。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1596
V V Bodrova, S G Khaspekova, O N Shustova, N V Tsvetaeva, A V Mazurov

Immune thrombocytopenia (ITP) is one of the most common causes of decreased platelet count. Bleeding is the main clinical symptom of ITP; although its severity correlates with the depth of thrombocytopenia, it may also depend on changes in the functional activity of platelets. In this study we have compared platelet functional activity in healthy volunteers (HV) and in ITP patients, as well as in groups of ITP patients with different levels of bleeding. The study included 65 HV and 84 ITP patients. Platelet activity was assessed by flow cytometry. Platelets were activated with thrombin receptor activating peptide (TRAP) or ADP, and the exposure of activation markers, activated form of glycoprotein (GP) IIb-IIIa and alpha-granule membrane protein P-selectin, was determined on their surface by measuring the binding of PAC-1 and CD62P antibodies, respectively. Platelet-associated IgG (PA-IgG, an indicator of the level of antiplatelet autoantibodies), the percentage of "young" reticular platelets (RP, %) and platelet light scatter (an indicator of their size) were also assessed using flow cytofluorimetry. Platelet binding of PAC-1 (and, to a lesser extent, CD62P binding) was lower in ITP patients than in HV. In ITP patients, PAC-1 binding inversely correlated with the PA-IgG content. In contrast to HV, in ITP patients, PAC-1 and CD62P binding did not directly correlate with the platelet size and RP, %. In ITP patients with severe bleeding, the platelet count was lower, PAC-1 and CD62P binding was reduced and PA-IgG and RP, % levels were increased. Thus, a decrease in the content of activation markers on the platelet surface was registered in ITP patients; it was more pronounced in patients with severe bleeding. It is suggested that the cause of this decrease may be due to the effect of autoantibodies (PA-IgG) on platelets, and in particular on GP IIb-IIIa.

免疫性血小板减少症(ITP)是血小板计数减少的最常见原因之一。出血是ITP的主要临床症状;虽然其严重程度与血小板减少的深度有关,但它也可能取决于血小板功能活性的变化。在这项研究中,我们比较了健康志愿者(HV)和ITP患者以及不同程度出血的ITP患者组的血小板功能活性。该研究包括65名HV和84名ITP患者。流式细胞术检测血小板活性。用凝血酶受体激活肽(TRAP)或ADP激活血小板,通过测量PAC-1和CD62P抗体的结合,分别测定活化标记物糖蛋白(GP) IIb-IIIa和α颗粒膜蛋白p -选择素的活化形式在血小板表面的暴露。血小板相关IgG (PA-IgG,抗血小板自身抗体水平的指标)、“年轻”网状血小板百分比(RP, %)和血小板光散射(血小板大小的指标)也使用流式细胞荧光法进行评估。血小板结合PAC-1的ITP患者比HV患者低(在较小程度上,CD62P结合)。在ITP患者中,PAC-1结合与PA-IgG含量呈负相关。与HV相比,在ITP患者中,PAC-1和CD62P结合与血小板大小和RP %没有直接相关性。伴有严重出血的ITP患者血小板计数较低,PAC-1和CD62P结合减少,PA-IgG和RP, %水平升高。因此,ITP患者血小板表面活化标志物含量下降;在严重出血的患者中更为明显。这种下降的原因可能是由于自身抗体(PA-IgG)对血小板的影响,特别是对GP IIb-IIIa的影响。
{"title":"Platelet functional activity in patients with immune thrombocytopenia.","authors":"V V Bodrova, S G Khaspekova, O N Shustova, N V Tsvetaeva, A V Mazurov","doi":"10.18097/PBMCR1596","DOIUrl":"https://doi.org/10.18097/PBMCR1596","url":null,"abstract":"<p><p>Immune thrombocytopenia (ITP) is one of the most common causes of decreased platelet count. Bleeding is the main clinical symptom of ITP; although its severity correlates with the depth of thrombocytopenia, it may also depend on changes in the functional activity of platelets. In this study we have compared platelet functional activity in healthy volunteers (HV) and in ITP patients, as well as in groups of ITP patients with different levels of bleeding. The study included 65 HV and 84 ITP patients. Platelet activity was assessed by flow cytometry. Platelets were activated with thrombin receptor activating peptide (TRAP) or ADP, and the exposure of activation markers, activated form of glycoprotein (GP) IIb-IIIa and alpha-granule membrane protein P-selectin, was determined on their surface by measuring the binding of PAC-1 and CD62P antibodies, respectively. Platelet-associated IgG (PA-IgG, an indicator of the level of antiplatelet autoantibodies), the percentage of \"young\" reticular platelets (RP, %) and platelet light scatter (an indicator of their size) were also assessed using flow cytofluorimetry. Platelet binding of PAC-1 (and, to a lesser extent, CD62P binding) was lower in ITP patients than in HV. In ITP patients, PAC-1 binding inversely correlated with the PA-IgG content. In contrast to HV, in ITP patients, PAC-1 and CD62P binding did not directly correlate with the platelet size and RP, %. In ITP patients with severe bleeding, the platelet count was lower, PAC-1 and CD62P binding was reduced and PA-IgG and RP, % levels were increased. Thus, a decrease in the content of activation markers on the platelet surface was registered in ITP patients; it was more pronounced in patients with severe bleeding. It is suggested that the cause of this decrease may be due to the effect of autoantibodies (PA-IgG) on platelets, and in particular on GP IIb-IIIa.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"288-299"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The inhibitory effect of mometasone and nortriptyline on the production of proinflammatory cytokines by blood mononuclear cells of patients with allergic rhinitis under conditions of stimulated immune response. 莫米松和去甲替林在刺激免疫应答条件下对变应性鼻炎患者血单个核细胞产生促炎细胞因子的抑制作用
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1568
T V Mironova, A D Tahanovich, A G Kadushkin, V V Makarevich, I P Shilovskiy, M R Khaitov

Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal mucosa; it develops when the immune system reacts to an allergen. Side effects of topical glucocorticosteroids (GCS) used for AR treatment, the development of steroid resistance in patients and the continuing increase in morbidity explain the clear need to search for new approaches for AR treatment. The tricyclic antidepressant nortriptyline has demonstrated anti-inflammatory properties in a number of experimental studies, as well as its ability to complement the action of corticosteroids. The aim of this study was to compare the effects of nortriptyline and the synthetic GCS mometasone on the culture of mononuclear cells (MNC) of AR patients. Blood MNCs from six AR patients were cultured in the presence of nortriptyline or mometasone, and then type 1, type 2, or type 17 immune response (IR) were stimulated by adding recombinant activator proteins (IL-2, IL-25, IL-33, TSLP, IL-12, IL-1β, IL-23). After 3 days, concentrations of proinflammatory cytokines TNF-α, IFN-γ, IL-6, IL-8, and IL-4 were determined in cell supernatants by enzyme immunoassay. Mometasone (10⁻⁸ M final concentration) effectively suppressed the secretion of proinflammatory cytokines TNF-α, IFN-γ, IL-6, and IL-8 under conditions of stimulation of IR of all types. A similar decrease in secretion, although less pronounced, occurred when stimulated cells were cultured in the presence of nortriptyline. The concentration of TNF-α in the culture medium decreased under these conditions both with stimulation of type 1, type 2, and type 17 IR. The level of IFN-γ secretion decreased only in the case of type 1 and type 17 IR as compared to MNCs with the stimulated IR, which were cultured without this inhibitor. The level of IL-6 secretion decreased only in the culture medium of cells with stimulated type 1 and type 2 IR and IL-8 secretion decreased only under conditions of stimulated type 1 IR. This study has shown that mometasone and nortriptyline are able to suppress the secretion of proinflammatory cytokines by blood cells; their effect is selective and depends on the IR type.

过敏性鼻炎(AR)是一种慢性鼻黏膜炎症性疾病;当免疫系统对过敏原产生反应时,它就会产生。用于AR治疗的外用糖皮质激素(GCS)的副作用,患者中类固醇耐药性的发展以及发病率的持续增加说明了寻找AR治疗新方法的明确需要。三环抗抑郁药去甲替林在许多实验研究中显示出抗炎特性,以及它补充皮质类固醇作用的能力。本研究的目的是比较去甲替林和合成GCS莫米松对AR患者单核细胞(MNC)培养的影响。6例AR患者血液MNCs在去甲替林或莫米松存在下培养,然后通过添加重组激活蛋白(IL-2、IL-25、IL-33、TSLP、IL-12、IL-1β、IL-23)刺激1型、2型或17型免疫反应(IR)。3 d后,采用酶免疫法测定细胞上清液中促炎因子TNF-α、IFN-γ、IL-6、IL-8和IL-4的浓度。莫米松(10 -⁸M终浓度)在所有类型的IR刺激条件下有效抑制促炎细胞因子TNF-α、IFN-γ、IL-6和IL-8的分泌。当受刺激的细胞在去甲替林的存在下培养时,出现了类似的分泌减少,尽管不那么明显。在1型、2型和17型IR刺激下,培养基中TNF-α的浓度均下降。IFN-γ的分泌水平仅在1型和17型IR的情况下下降,与受刺激IR的跨国公司相比,没有这种抑制剂的培养。IL-6分泌水平仅在受1型和2型IR刺激的细胞培养基中下降,IL-8分泌水平仅在受1型IR刺激的条件下下降。本研究表明莫米松和去甲替林能够抑制血细胞分泌促炎细胞因子;它们的作用是选择性的,取决于IR类型。
{"title":"The inhibitory effect of mometasone and nortriptyline on the production of proinflammatory cytokines by blood mononuclear cells of patients with allergic rhinitis under conditions of stimulated immune response.","authors":"T V Mironova, A D Tahanovich, A G Kadushkin, V V Makarevich, I P Shilovskiy, M R Khaitov","doi":"10.18097/PBMCR1568","DOIUrl":"https://doi.org/10.18097/PBMCR1568","url":null,"abstract":"<p><p>Allergic rhinitis (AR) is a chronic inflammatory disease of the nasal mucosa; it develops when the immune system reacts to an allergen. Side effects of topical glucocorticosteroids (GCS) used for AR treatment, the development of steroid resistance in patients and the continuing increase in morbidity explain the clear need to search for new approaches for AR treatment. The tricyclic antidepressant nortriptyline has demonstrated anti-inflammatory properties in a number of experimental studies, as well as its ability to complement the action of corticosteroids. The aim of this study was to compare the effects of nortriptyline and the synthetic GCS mometasone on the culture of mononuclear cells (MNC) of AR patients. Blood MNCs from six AR patients were cultured in the presence of nortriptyline or mometasone, and then type 1, type 2, or type 17 immune response (IR) were stimulated by adding recombinant activator proteins (IL-2, IL-25, IL-33, TSLP, IL-12, IL-1β, IL-23). After 3 days, concentrations of proinflammatory cytokines TNF-α, IFN-γ, IL-6, IL-8, and IL-4 were determined in cell supernatants by enzyme immunoassay. Mometasone (10⁻⁸ M final concentration) effectively suppressed the secretion of proinflammatory cytokines TNF-α, IFN-γ, IL-6, and IL-8 under conditions of stimulation of IR of all types. A similar decrease in secretion, although less pronounced, occurred when stimulated cells were cultured in the presence of nortriptyline. The concentration of TNF-α in the culture medium decreased under these conditions both with stimulation of type 1, type 2, and type 17 IR. The level of IFN-γ secretion decreased only in the case of type 1 and type 17 IR as compared to MNCs with the stimulated IR, which were cultured without this inhibitor. The level of IL-6 secretion decreased only in the culture medium of cells with stimulated type 1 and type 2 IR and IL-8 secretion decreased only under conditions of stimulated type 1 IR. This study has shown that mometasone and nortriptyline are able to suppress the secretion of proinflammatory cytokines by blood cells; their effect is selective and depends on the IR type.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"300-307"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144990899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the redox signaling system (H2О2 and the thiol system) in the regulation of the functional activity of nervous tissue in health and disease. 氧化还原信号系统(H2О2和硫醇系统)在健康和疾病中调节神经组织功能活动中的作用。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1588
E E Dubinina, L V Shchedrina, N A Gomzyakova

The review highlights the role of reactive oxygen species (ROS) and the thiol system in the regulation of functional activity of neurons. Their controlling function has been analyzed in the context of processes of synaptic plasticity and functioning of neurotrophins, as well as participation in such cellular processes as proliferation, apoptosis, and cell aging. Special attention has been paid to the role of individual components of the thiol system, their interaction with H2О2 in the regulation of the redox signaling system of cells. Summarizing literature data reflecting the participation of H2О2 in the regulation of key metabolic cascades of nervous tissue and own results we have come to conclusion about the dual nature of the stress system components depending on the functional state of the organism. The manifestation of their toxic effect, first of all, depends on their concentration and chemical structure.

本文综述了活性氧(ROS)和硫醇系统在神经元功能活动调控中的作用。在突触可塑性和神经营养物质功能的过程中,以及参与细胞增殖、细胞凋亡和细胞衰老等细胞过程中,分析了它们的控制功能。特别注意的是硫醇系统的各个组成部分的作用,它们与H2О2在细胞氧化还原信号系统的调节中的相互作用。总结反映H2О2参与神经组织关键代谢级联调节的文献数据和我们自己的结果,我们得出了依赖于生物体功能状态的应激系统成分的双重性质。它们的毒性作用的表现,首先取决于它们的浓度和化学结构。
{"title":"The role of the redox signaling system (H2О2 and the thiol system) in the regulation of the functional activity of nervous tissue in health and disease.","authors":"E E Dubinina, L V Shchedrina, N A Gomzyakova","doi":"10.18097/PBMCR1588","DOIUrl":"10.18097/PBMCR1588","url":null,"abstract":"<p><p>The review highlights the role of reactive oxygen species (ROS) and the thiol system in the regulation of functional activity of neurons. Their controlling function has been analyzed in the context of processes of synaptic plasticity and functioning of neurotrophins, as well as participation in such cellular processes as proliferation, apoptosis, and cell aging. Special attention has been paid to the role of individual components of the thiol system, their interaction with H2О2 in the regulation of the redox signaling system of cells. Summarizing literature data reflecting the participation of H2О2 in the regulation of key metabolic cascades of nervous tissue and own results we have come to conclusion about the dual nature of the stress system components depending on the functional state of the organism. The manifestation of their toxic effect, first of all, depends on their concentration and chemical structure.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"243-255"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glycyrrhizic acid: novel potential protein targets. 甘草酸:新的潜在蛋白靶点。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1595
P V Ershov, E O Yablokov, L A Kaluzhskiy, Yu V Mezentsev, O V Gnedenko, M A Konstantinov, I Yu Toropygin, A S Ivanov

To date, a large body of data has been accumulated on the biological activity of a low-toxic natural glycoside, glycyrrhizic acid (GA), but the mechanism of its action at the molecular level has not been fully studied. Expanding knowledge about the spectrum of cellular protein targets of GA contributes to understanding new features of pharmacodynamics. The aim of the work was the experimental identification of a tissue-specific spectrum of protein molecules interacting with GA in a model system. Samples of an intact rat liver tissue lysate were incubated with GA covalently immobilized on EAH-Sepharose 4B, followed by elution of affinity-isolated protein molecules and their trypsinolysis. Using mass spectrometric analysis, 88 potential protein targets of GA were identified. According to the results of gel chromatographic separation of the rat liver lysate and semi-quantitative analysis of proteins, GA influenced Aldh6a1, Decr1, and Sod1 in fractions. Molecular docking in the Flare™ program used to model protein complexes with GA, resulted in selection of 5 proteins (Acox2, Acr1c9, Maoa, Mat1a, Nalcn), which formed complexes with GA with the most favorable ΔG and Rank score parameters. More than half (57%) of the affinity-isolated proteins are involved in the processes of basic cellular metabolism and biotransformation of endogenous and exogenous compounds. Data on the associations of potential protein targets of GA with diseases and different types of biological activity of GA have been systematized and compared.

迄今为止,关于低毒天然糖苷甘草酸(glycyrrhizic acid, GA)的生物活性已经积累了大量的数据,但其在分子水平上的作用机制尚未得到充分的研究。扩大对GA细胞蛋白靶点谱的认识有助于了解其药效学的新特征。该工作的目的是在模型系统中实验鉴定与GA相互作用的组织特异性蛋白质分子谱。将完整的大鼠肝组织裂解液样品与以EAH-Sepharose 4B共价固定的GA一起孵育,然后对亲和分离的蛋白分子进行洗脱并对其进行胰蛋白酶水解。通过质谱分析,鉴定出了88个GA的潜在蛋白靶点。大鼠肝裂解液凝胶层析分离及半定量蛋白分析结果显示,GA对Aldh6a1、Decr1和Sod1组分有影响。在用于模拟GA蛋白复合物的Flare™程序中的分子对接,选择了5个蛋白(Acox2, Acr1c9, Maoa, Mat1a, Nalcn),它们与GA形成了具有最有利ΔG和Rank评分参数的复合物。超过一半(57%)的亲和分离蛋白参与内源性和外源性化合物的基本细胞代谢和生物转化过程。关于GA的潜在蛋白靶点与疾病的关联以及GA不同类型的生物活性的数据已经被系统化和比较。
{"title":"Glycyrrhizic acid: novel potential protein targets.","authors":"P V Ershov, E O Yablokov, L A Kaluzhskiy, Yu V Mezentsev, O V Gnedenko, M A Konstantinov, I Yu Toropygin, A S Ivanov","doi":"10.18097/PBMCR1595","DOIUrl":"https://doi.org/10.18097/PBMCR1595","url":null,"abstract":"<p><p>To date, a large body of data has been accumulated on the biological activity of a low-toxic natural glycoside, glycyrrhizic acid (GA), but the mechanism of its action at the molecular level has not been fully studied. Expanding knowledge about the spectrum of cellular protein targets of GA contributes to understanding new features of pharmacodynamics. The aim of the work was the experimental identification of a tissue-specific spectrum of protein molecules interacting with GA in a model system. Samples of an intact rat liver tissue lysate were incubated with GA covalently immobilized on EAH-Sepharose 4B, followed by elution of affinity-isolated protein molecules and their trypsinolysis. Using mass spectrometric analysis, 88 potential protein targets of GA were identified. According to the results of gel chromatographic separation of the rat liver lysate and semi-quantitative analysis of proteins, GA influenced Aldh6a1, Decr1, and Sod1 in fractions. Molecular docking in the Flare™ program used to model protein complexes with GA, resulted in selection of 5 proteins (Acox2, Acr1c9, Maoa, Mat1a, Nalcn), which formed complexes with GA with the most favorable ΔG and Rank score parameters. More than half (57%) of the affinity-isolated proteins are involved in the processes of basic cellular metabolism and biotransformation of endogenous and exogenous compounds. Data on the associations of potential protein targets of GA with diseases and different types of biological activity of GA have been systematized and compared.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"270-282"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction of antirenalase antibodies with recombinant human renalases 1 and 2 and their C-terminal regions encoded by the alternative exones. 抗肾化酶抗体与重组人肾化酶1和2的相互作用及其由替代外显子编码的c端区域。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1608
V I Fedchenko, A A Kaloshin, S A Kaloshina, O A Buneeva, A T Kopylov, A E Medvedev

The interaction of antirenalase antibodies with full-length recombinant human renalases RNLS1 and RNLS2, as well as fragments of these proteins encoded by alternative exons 9 and 10 and expressed as fusion proteins with dihydrofolate reductase (DHFR) in Escherichia coli cells has been investigated. In this study we used custom made polyclonal antibodies to the full-length recombinant RNLS1 (amino acid residues (aa) 1-342), created at our request, as well as commercially available monoclonal antibodies to the renalase fragment (aa - 18-342), specific for the RNLS1 isoform and its C-terminal sequence encoded by exon 9. According to Western blot analysis, the antibodies interacted not only with recombinant RNLS1 and RNLS2 preparations, but also with fusion proteins containing C-terminal sequences specific for these isoforms (DHFR-RNLS-9ex and DHFR-RNLS-10ex). The results obtained indicate that the studied antibodies, in addition to their direct targets, also "recognized" other protein constructs of RNLS1 and RNLS2, which were absent in the immunogen preparations used for antibody generation.

研究了抗肾化酶抗体与全长重组人肾化酶RNLS1和RNLS2的相互作用,以及这些蛋白由9和10外显子编码并在大肠杆菌细胞中与二氢叶酸还原酶(DHFR)融合表达的片段。在这项研究中,我们使用了根据我们的要求定制的全长重组RNLS1(氨基酸残基(aa) 1-342)的多克隆抗体,以及市售的renalase片段(aa - 18-342)的单克隆抗体,该单克隆抗体针对RNLS1亚型及其外显子9编码的c端序列。根据Western blot分析,抗体不仅与重组RNLS1和RNLS2制剂相互作用,而且与含有这些同种异构体特异性c端序列的融合蛋白(DHFR-RNLS-9ex和DHFR-RNLS-10ex)相互作用。结果表明,所研究的抗体除了其直接靶标外,还“识别”了RNLS1和RNLS2的其他蛋白结构,这些蛋白结构在用于抗体生成的免疫原制剂中是不存在的。
{"title":"Interaction of antirenalase antibodies with recombinant human renalases 1 and 2 and their C-terminal regions encoded by the alternative exones.","authors":"V I Fedchenko, A A Kaloshin, S A Kaloshina, O A Buneeva, A T Kopylov, A E Medvedev","doi":"10.18097/PBMCR1608","DOIUrl":"https://doi.org/10.18097/PBMCR1608","url":null,"abstract":"<p><p>The interaction of antirenalase antibodies with full-length recombinant human renalases RNLS1 and RNLS2, as well as fragments of these proteins encoded by alternative exons 9 and 10 and expressed as fusion proteins with dihydrofolate reductase (DHFR) in Escherichia coli cells has been investigated. In this study we used custom made polyclonal antibodies to the full-length recombinant RNLS1 (amino acid residues (aa) 1-342), created at our request, as well as commercially available monoclonal antibodies to the renalase fragment (aa - 18-342), specific for the RNLS1 isoform and its C-terminal sequence encoded by exon 9. According to Western blot analysis, the antibodies interacted not only with recombinant RNLS1 and RNLS2 preparations, but also with fusion proteins containing C-terminal sequences specific for these isoforms (DHFR-RNLS-9ex and DHFR-RNLS-10ex). The results obtained indicate that the studied antibodies, in addition to their direct targets, also \"recognized\" other protein constructs of RNLS1 and RNLS2, which were absent in the immunogen preparations used for antibody generation.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"283-287"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of the course of chronic obstructive pulmonary disease by blood biomarkers. 血液生物标志物对慢性阻塞性肺疾病病程的预测。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-09-01 DOI: 10.18097/PBMCR1579
D I Murashka, A D Tahanovich, M M Kauhanka, I A Nikitina, A V Kolb, L S Bogush, E I Davidovskaya, O A Budnik

Chronic obstructive pulmonary disease (COPD) is one of the most common pathologies of the respiratory system; it is characterized by increasing airflow limitation. The course of COPD is unstable and is often accompanied by periods of exacerbation, when respiratory symptoms of the disease significantly increase. The frequency of COPD exacerbations is an important predictor of its course, allowing to predict the decline in lung tissue function and the outcome of the disease. Currently, the risk of future COPD exacerbations in a patient is assessed based on the history of previous exacerbations, and the improvement of his condition is evaluated on the basis of the weakening of COPD symptoms. However, the lack of objective criteria complicates unambiguous verdict on the probability of acute condition development and the effectiveness of treatment of COPD patients. Based on the analysis of literature data we propose determination of the levels of chemokines (CXCL5, CXCL8, CXCR1/2, CD44v6), HIF-1α, procalcitonin, albumin and C-reactive protein, leukocyte cells, as well as their possible combination in the peripheral blood as an informative tool for evaluation in COPD patients.

慢性阻塞性肺疾病(COPD)是最常见的呼吸系统疾病之一;它的特点是增加气流限制。慢性阻塞性肺病病程不稳定,常伴有加重期,此时疾病的呼吸系统症状显著加重。COPD恶化的频率是其病程的重要预测因子,可以预测肺组织功能的下降和疾病的结果。目前,对患者未来COPD加重的风险评估是基于既往COPD加重史,对病情改善的评估是基于COPD症状的减弱。然而,缺乏客观标准使得对COPD患者急性病情发展的概率和治疗效果的明确判断变得复杂。基于对文献数据的分析,我们建议测定外周血中趋化因子(CXCL5、CXCL8、CXCR1/2、CD44v6)、HIF-1α、降钙素原、白蛋白和c反应蛋白、白细胞的水平,以及它们的可能组合,作为评估COPD患者的信息工具。
{"title":"Prediction of the course of chronic obstructive pulmonary disease by blood biomarkers.","authors":"D I Murashka, A D Tahanovich, M M Kauhanka, I A Nikitina, A V Kolb, L S Bogush, E I Davidovskaya, O A Budnik","doi":"10.18097/PBMCR1579","DOIUrl":"https://doi.org/10.18097/PBMCR1579","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is one of the most common pathologies of the respiratory system; it is characterized by increasing airflow limitation. The course of COPD is unstable and is often accompanied by periods of exacerbation, when respiratory symptoms of the disease significantly increase. The frequency of COPD exacerbations is an important predictor of its course, allowing to predict the decline in lung tissue function and the outcome of the disease. Currently, the risk of future COPD exacerbations in a patient is assessed based on the history of previous exacerbations, and the improvement of his condition is evaluated on the basis of the weakening of COPD symptoms. However, the lack of objective criteria complicates unambiguous verdict on the probability of acute condition development and the effectiveness of treatment of COPD patients. Based on the analysis of literature data we propose determination of the levels of chemokines (CXCL5, CXCL8, CXCR1/2, CD44v6), HIF-1α, procalcitonin, albumin and C-reactive protein, leukocyte cells, as well as their possible combination in the peripheral blood as an informative tool for evaluation in COPD patients.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 4","pages":"256-269"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144990961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative analysis of the effect of hybrid vaterite microparticles with various polysaccharides on neutrophils activity. 不同多糖杂化水晶石微粒对中性粒细胞活性影响的比较分析。
Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2025-06-01 DOI: 10.18097/PBMCR1561
D V Grigorieva, E V Mikhalchik, D V Mosievich, P I Mishin, N G Balabushevich, O M Panasenko, A V Sokolov, I V Gorudko

Carriers based on natural biominerals attract much attention in the context of the development of new drug delivery systems. In this study, the effects of native (CC) and hybrid vaterite microparticles with the inclusion of dextran sulfate (CCDS), chondroitin sulfate (CCCS), heparin (CCHE), fucoidan (CCFU), and pectin (CCPE) have been investigated on the viability and functional activity of neutrophils. Among the tested preparations, only CCFU exhibited a slight cytotoxic effect. Native CC stimulated actin cytoskeleton rearrangements and cell production of reactive oxygen species (ROS), which decreased in the presence of diphenyleneiodonium chloride (DPI), an inhibitor of NADPH oxidase assembly. The CC-induced NADPH oxidase activation was reduced in the presence of inhibitors of non-receptor tyrosine kinases of the Src family, phosphatidylinositol 3-kinase (PI3K), and phospholipase C (PLC). Similar to native CC, hybrid vaterite microparticles also initiated ROS production by neutrophils. After addition of CC and hybrid vaterite microparticles (except CCDS), an increase in the number of neutrophils characterized by higher values of the side scattering value was detected thus indicating a change in the morphological characteristics of the cells. Given the ability of hybrid vaterite microparticles with polysaccharides to activate neutrophil NADPH oxidase, they could be promising systems for the delivery of antibacterial and antiviral drugs.

基于天然生物矿物质的载体在新型给药系统的开发中备受关注。本研究研究了含有硫酸葡聚糖(CCDS)、硫酸软骨素(CCCS)、肝素(CCHE)、岩藻聚糖(CCFU)和果胶(CCPE)的天然(CC)和杂交水晶石微粒对中性粒细胞活力和功能活性的影响。在被试制剂中,只有CCFU表现出轻微的细胞毒性作用。天然CC刺激肌动蛋白细胞骨架重排和细胞活性氧(ROS)的产生,在NADPH氧化酶组装抑制剂二苯二氯铵(DPI)存在下,活性氧(ROS)的产生减少。在Src家族非受体酪氨酸激酶、磷脂酰肌醇3-激酶(PI3K)和磷脂酶C (PLC)抑制剂的存在下,cc诱导的NADPH氧化酶活化降低。与原生CC类似,杂交鼠体微粒也通过中性粒细胞启动ROS的产生。在加入CC和杂交vaterite微粒子(CCDS除外)后,检测到以较高侧散射值为特征的中性粒细胞数量增加,从而表明细胞形态特征发生了变化。考虑到含有多糖的杂化水蛭微粒能够激活中性粒细胞NADPH氧化酶,它们可能是有希望的抗菌和抗病毒药物递送系统。
{"title":"Comparative analysis of the effect of hybrid vaterite microparticles with various polysaccharides on neutrophils activity.","authors":"D V Grigorieva, E V Mikhalchik, D V Mosievich, P I Mishin, N G Balabushevich, O M Panasenko, A V Sokolov, I V Gorudko","doi":"10.18097/PBMCR1561","DOIUrl":"https://doi.org/10.18097/PBMCR1561","url":null,"abstract":"<p><p>Carriers based on natural biominerals attract much attention in the context of the development of new drug delivery systems. In this study, the effects of native (CC) and hybrid vaterite microparticles with the inclusion of dextran sulfate (CCDS), chondroitin sulfate (CCCS), heparin (CCHE), fucoidan (CCFU), and pectin (CCPE) have been investigated on the viability and functional activity of neutrophils. Among the tested preparations, only CCFU exhibited a slight cytotoxic effect. Native CC stimulated actin cytoskeleton rearrangements and cell production of reactive oxygen species (ROS), which decreased in the presence of diphenyleneiodonium chloride (DPI), an inhibitor of NADPH oxidase assembly. The CC-induced NADPH oxidase activation was reduced in the presence of inhibitors of non-receptor tyrosine kinases of the Src family, phosphatidylinositol 3-kinase (PI3K), and phospholipase C (PLC). Similar to native CC, hybrid vaterite microparticles also initiated ROS production by neutrophils. After addition of CC and hybrid vaterite microparticles (except CCDS), an increase in the number of neutrophils characterized by higher values of the side scattering value was detected thus indicating a change in the morphological characteristics of the cells. Given the ability of hybrid vaterite microparticles with polysaccharides to activate neutrophil NADPH oxidase, they could be promising systems for the delivery of antibacterial and antiviral drugs.</p>","PeriodicalId":8889,"journal":{"name":"Biomeditsinskaya khimiya","volume":"71 3","pages":"227-238"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomeditsinskaya khimiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1